Table 1. Baseline characteristics of 253 tuberculosis patients by HIV status in a tertiary care hospital in Rwanda.
| HIV positive | HIV negative | p-value | |
| n = 167 | n = 86 | ||
| n (%) | n (%) | ||
| Demographics | |||
| Age in years, median (IQR) | 36 (30–42) | 32 (24–36) | 0.0004 |
| Female sex | 76 (45.5) | 39 (45) | ns |
| Married | 77 (46) | 32 (37) | ns |
| No formal education | 17 (10) | 9 (10) | ns |
| Unemployed or student | 44 (26) | 44 (51) | <0.0001 |
| Alcohol abuse | 124 (73) | 48 (56) | 0.003 |
| Smoking, active | 63 (38) | 21 (24) | 0.033 |
| Hospital admission | 130 (78) | 23 (27) | <0.0001 |
| Clinical | |||
| Body mass indexa, median (IQR) | 17,9 (16,0–20,2) | 18,9 (16,8–20,4) | ns |
| Hemoglobin (g/dL), median (IQR) | 9,9 (8,4–12) | 13,1 (11,6–14,5) | <0.0001 |
| Site of TBb | |||
| Pulmonary | 54 (32) | 48 (55) | 0.001 |
| Extrapulmonary | 77 (46) | 31 (36) | |
| Pulmonary and extrapulmonary | 36 (22) | 7 (8) | |
| Smear positivity (n = 144)c | 39 (44) | 39 (71) | 0.002 |
| Positive hepatitis B surface antigen (n = 135)d | 6 (7) | 1 (2) | ns |
| Previous TB treatment | 25 (15) | 4 (5) | 0.015 |
| Fluconazole treatment e | 32 (19) | 0 (0) | <0.0001 |
| Traditional drugs e | 12 (7) | 7 (8) | ns |
| Severe adverse event | 58 (35) | 6 (7) | <0.0001 |
a
Body mass index is defined as the weight in kilograms divided by the square of the height in meters.
b
TB can affect multiples sites in one patient.
c
Smear-positivity from any biological specimen, including sputum, lymph node aspirate, etc.
d
Hepatitis B surface antigen positive in 6/87 hiv-infected and 1/48 hiv-uninfected persons.
e
within one week prior to admission.
p-value<0.05; IQR = interquartile range.